Vanguard Global Advisers
BHC icon

Vanguard Global Advisers’s Bausch Health BHC Stock Holding History

Vanguard Global Advisers’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.22M Buy
855,700
+59,864
+8% +$321K ﹤0.01% 855
2026
Q1 		$4.3M Buy
+795,836
New +$4.76M ﹤0.01% 817

Other funds holding BHC

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Global Advisers's BHC Position: Q2 2026 in Review

Vanguard Global Advisers increased its Bausch Health (BHC) stake by 7.5% in Q2 2026, buying an estimated $321K and bringing the position to 855,700 shares worth $4.22M. The position accounts for ﹤0.01% of the portfolio, ranked #855.

Vanguard Global Advisers first reported a position in BHC in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.3M in Q1 2026. 221 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Vanguard Global Advisers held 855,700 shares of Bausch Health worth $4.22M as of Q2 2026.
  • Vanguard Global Advisers bought 59,864 Bausch Health shares in Q2 2026, an estimated $321K.
  • Bausch Health made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #855 holding.
  • Vanguard Global Advisers first reported a position in Bausch Health in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Bausch Health position peaked at $4.3M in Q1 2026.
  • 221 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.